The trajectory of Sildenafil presents a complex picture for those considering investment. While the initial launch generated massive profits, the end of its exclusive rights opened the avenue to generic alternatives, https://totalbookmarking.com/story21692960/the-copyright-and-pharma-a-risky-investment